Taxing Times for French Pharma - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Taxing Times for French Pharma
As the French Presidential campaign is underway, and politicians collaborate with businesses to revive a flagging economy, the pharmaceutical industry seizes the chance to lobby for equitable taxation to give the sector a much-needed boost.

Pharmaceutical Technology Europe


1. ARIIS, "Pétition d'ARIIS pour les présidentielles 2012" (ARIIS Website, 2012)., accessed 4 Apr., 2012.

2. A. Torsoli, "French Drugmakers Say Pricing Policy May Hamper Industry" (Bloomberg Website, 2012)., 4 Apr., 2012

3. The Pharma Letter, "Tax system for French drug firms to change" (The Pharma Letter Website, 2012)., accessed 4 Apr., 2012.

4. J. Cuadrado and C. Damiano, "French taxes specific to the pharmaceutical industry: cutting the health expenses or a different way of taxing the profitability of the pharmaceutical industry in France" in Tax on Transactions multi-jurisdictional guide (Practical Law Company Website, 2011)., accessed 4 Apr., 2012.

5. Anon, "France loses AAA rating as euro governments downgraded" (BBC News Website, Jan. 12, 2012)., accessed 4 Apr., 2012.

6. H. Israël and C. Guionnet-Moalic, "France: How the Reform of the Tax Applicable to Pharmaceutical Product Turnover Will Affect Entities in this Field" (mondaq Website, 2005). accessed 4 Apr., 2012.

7. CSIS, Meeting of the Health Industries Strategic Advisory Board (Ministère de l'Économie, des Finances et de l'Industrie website, 2012)., accessed 4 Apr., 2012.

8. Focus Reports, "France: The French Revolution" (Focus Reports Website, 2010)., accessed 4 Apr., 2012.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here